Literature DB >> 12392761

Characterization of human aggrecanase 2 (ADAM-TS5): substrate specificity studies and comparison with aggrecanase 1 (ADAM-TS4).

Micky D Tortorella1, Rui-Qin Liu, Timothy Burn, Robert C Newton, Elizabeth Arner.   

Abstract

ADAM-TS5 (aggrecanase 2), one of two cartilage aggrecanases is a member of the ADAM protein family. Like ADAM-TS4 (aggrecanase 1) the enzyme cleaves cartilage aggrecan at the Glu(373)-Ala(374) bond, a marker of aggrecanase activity. In this study we have characterized the substrate specificity of ADAM-TS5 and compared it with that of ADAM-TS4. The recombinant human ADAM-TS5, like ADAM-TS4 cleaves aggrecan at Glu(1480)-Gly(1481), Glu(1667)-Gly(1668), Glu(1771)-Ala(1772) and Glu(1871)-Leu(1872) bonds more readily than at the Glu(373)-Ala(374) bond. In addition, ADAM-TS5 exhibited an additional site of cleavage in the region spanning residues Gly(1481) and Glu(1667), representing a unique cleavage of ADAM-TS5. ADAM-TS5 cleaved aggrecan approximately 2-fold slower than ADAM-TS4. Neither ADAM-TS5 nor ADAM-TS4 was able to cleave the extracellular matrix proteins fibronectin, thrombospondin, type I collagen, type II collagen, gelatin or general protein substrates such as casein and transferrin. Finally, the zymogen of stromelysin (MMP-3) was not activated by either ADAM-TS4 or ADAM-TS5. Copyright 2002 Elsevier Science B.V. and International Society of Matrix Biology

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12392761     DOI: 10.1016/s0945-053x(02)00069-0

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  33 in total

1.  Variations in aggrecan structure modulate its susceptibility to aggrecanases.

Authors:  Peter J Roughley; James Barnett; Fengrong Zuo; John S Mort
Journal:  Biochem J       Date:  2003-10-01       Impact factor: 3.857

2.  A quantitative assay for aggrecanase activity.

Authors:  Horst Will; Matthias Dettloff; Peter Bendzkô; Peter Sveshnikov
Journal:  J Biomol Tech       Date:  2005-12

3.  Domain shuffling and the evolution of vertebrates.

Authors:  Takeshi Kawashima; Shuichi Kawashima; Chisaki Tanaka; Miho Murai; Masahiko Yoneda; Nicholas H Putnam; Daniel S Rokhsar; Minoru Kanehisa; Nori Satoh; Hiroshi Wada
Journal:  Genome Res       Date:  2009-05-14       Impact factor: 9.043

4.  The structure and degradation of aggrecan in human intervertebral disc.

Authors:  Peter J Roughley; Lee I Melching; Terrence F Heathfield; Richard H Pearce; John S Mort
Journal:  Eur Spine J       Date:  2006-05-31       Impact factor: 3.134

5.  Cleavage within Reelin repeat 3 regulates the duration and range of the signaling activity of Reelin protein.

Authors:  Mari Koie; Kyoko Okumura; Arisa Hisanaga; Takana Kamei; Kazutomo Sasaki; Mengyan Deng; Atsushi Baba; Takao Kohno; Mitsuharu Hattori
Journal:  J Biol Chem       Date:  2014-03-18       Impact factor: 5.157

6.  MMPs are less efficient than ADAMTS5 in cleaving aggrecan core protein.

Authors:  Michaela Durigova; Hideaki Nagase; John S Mort; Peter J Roughley
Journal:  Matrix Biol       Date:  2010-11-03       Impact factor: 11.583

7.  ADAMTS9 activation by interleukin 1 beta via NFATc1 in OUMS-27 chondrosarcoma cells and in human chondrocytes.

Authors:  Kursat Oguz Yaykasli; Toshitaka Oohashi; Satoshi Hirohata; Omer Faruk Hatipoglu; Kiichi Inagawa; Kadir Demircan; Yoshifumi Ninomiya
Journal:  Mol Cell Biochem       Date:  2008-12-04       Impact factor: 3.396

8.  Critical amino acids in the active site of meprin metalloproteinases for substrate and peptide bond specificity.

Authors:  James P Villa; Greg P Bertenshaw; Judith S Bond
Journal:  J Biol Chem       Date:  2003-07-29       Impact factor: 5.157

9.  Nitric oxide enhances aggrecan degradation by aggrecanase in response to TNF-alpha but not IL-1beta treatment at a post-transcriptional level in bovine cartilage explants.

Authors:  A L Stevens; C A Wheeler; S R Tannenbaum; A J Grodzinsky
Journal:  Osteoarthritis Cartilage       Date:  2007-10-10       Impact factor: 6.576

10.  Biomimetic nucleus pulposus scaffold created from bovine caudal intervertebral disc tissue utilizing an optimal decellularization procedure.

Authors:  Christopher Fernandez; Alan Marionneaux; Sanjitpal Gill; Jeremy Mercuri
Journal:  J Biomed Mater Res A       Date:  2016-08-19       Impact factor: 4.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.